# Exploratory Study Assessing Synchronisation of Egg Sacs With Degarelix

> **NCT00434122** · PHASE2 · COMPLETED · sponsor: **Ferring Pharmaceuticals** · enrollment: 85 (actual)

## Conditions studied

- Infertility, Female

## Interventions

- **DRUG:** Degarelix mid-luteal, 2.5 mg
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00434122
- **Lead sponsor:** Ferring Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-03
- **Primary completion:** 2007-12
- **Final completion:** 2007-12
- **Target enrollment:** 85 (ACTUAL)
- **Last updated:** 2011-06-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00434122

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00434122, "Exploratory Study Assessing Synchronisation of Egg Sacs With Degarelix". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00434122. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*